Dr. Brad Tinkle presents “Introduction to Ehlers-Danlos Syndrome”.
To browse MORE VIDEO presentations by other EDS Experts – Click Here (then select “previous page” to view more recordings.)
About our speaker: Dr. Brad Tinkle
– Brad T. Tinkle, M.D., Ph.D., is the Medical Director of Clinical Genetics at Advocate Children’s Hospital in Chicagoland.
– His clinics include Ehlers-Danlos (for adults, children, and families) and pediatric Down’s Syndrome.
– Prior to his current position, Dr. Tinkle was a clinical and clinical molecular geneticist at Cincinnati Children’s Hospital Medical Center (CCHMC).
– He specializes in caring for individuals with heritable connective tissue disorders such as Ehlers-Danlos syndromes, Marfan syndrome, osteogenesis imperfecta, and achondroplasia among the many.
– Dr. Tinkle served as director of the Skeletal Dysplasia Center (CCHMC), co-director of the Marfan/Ehlers-Danlos syndrome clinic, as well as director of the Connective Tissue Clinic.
– He serves as associate director in the Clinical Molecular Genetics Laboratory at CCHMC.
– Brad T. Tinkle, M.D formerly served on the Board of Directors and on the Professional Advisory Network of the Ehlers-Danlos National Foundation.
– Dr. Tinkle earned a bachelor’s in science for engineering (BSE) in genetic engineering from Purdue University in 1989.
– He received his Ph.D. in Human Genetics from the George Washington University in the District of Columbia in 1995.
– Brad T. Tinkle, M.D attended medical school at Indiana University and completed a pediatric/clinical genetics residency at CCHMC.
– He also finished a fellowship in clinical molecular genetics at CCHMC following residency.
EDSawareness.com offers FREE Educational Sessions twice/month!
To receive webinar announcements via email, Click Here
To watch video RECORDINGS of previous presentations, Click Here
(then select “previous page” to view more recordings.)
To attend the next live session, Click Here
(then select the upcoming presenter’s announcement to view meeting log-in instructions.)
We appreciate your Likes and Comments